Target intelligence / Profile preview

Alpha-linolenic Acid Pathway (ALA Pathway)

Target: ALA Pathway
Molecular classification: Metabolic Pathway, Enzymatic Pathway

Overview

The alpha-linolenic acid (ALA) pathway is a series of enzymatic reactions responsible for converting the essential omega-3 fatty acid ALA into longer-chain and more unsaturated omega-3 fatty acids, primarily eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA). This pathway involves desaturation and elongation steps primarily in the endoplasmic reticulum. The efficiency of this pathway is influenced by various factors, including genetics, sex, and dietary intake. The longer-chain omega-3 fatty acids produced through this pathway play crucial roles in cell membrane structure, inflammation modulation, and neurological function.

Other names: n-3 Polyunsaturated Fatty Acid SynthesisOmega-3 Fatty Acid MetabolismALA Conversion to EPA and DHA

Mechanism of action

N/A - This is a metabolic pathway. Drugs interact with enzymes within the pathway or target downstream effects of pathway products.

Biological functions

Lipid MetabolismFatty Acid SynthesisCell Membrane Structure and FunctionInflammation ModulationNeurological Development

Disease associations

Cardiovascular Disease (indirect)Neurodegenerative Disease (indirect)Inflammatory Disorders (indirect)

Safety considerations

Potential for drug interactions (e.g., with anticoagulants)High doses of omega-3 supplements may cause gastrointestinal distressVariability in conversion efficiency between individuals

Interacting drugs

Statins (indirect, affecting lipid metabolism)

2 more in the full profile.

Biomarkers

Plasma ALA levelsPlasma EPA levelsPlasma DHA levelsRed Blood Cell EPA/DHA contentOmega-3 Index

Beyond the preview

Go deeper on Alpha-linolenic Acid Pathway (ALA Pathway).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Alpha-linolenic Acid Pathway (ALA Pathway).

Explore the full profile